Catalyst Wire Dossier Catalyst Wire Dossier

OPTIONELLE

LEVONORGESTREL TABLET, 1.5 MG · Strides Pharma Inc
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for OPTIONELLE, covering 2015-05-29 to 2022-10-25. Get the full timeline:

Most recent: FDA Approved: OPTIONELLE — Supplemental Application (Strides Pharma Inc)

See pricing